Successful Construction Of Eukaryotic Plasmids Containing HBV C Genotype

HBV infection remains a major health problem in the world. Several data have revealed that lamivudine can efficiently promote the treatment of hepatitis B. However, a long-term treatment of lamivudine leads to the emergence of lamivudine-resistant mutants (YMDD mutants), which hampers the anti-HBV therapy. Therefore, researches related to HBV lamivudine-resistant mechanism has been of great significance.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on October 1st, 2008